A alpha, Prostaglandin E2 CEP of the European Pharmacopoeia monograph is often referred to as a alpha, Prostaglandin E2 Certificate of Suitability (COS). The purpose of a alpha, Prostaglandin E2 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of alpha, Prostaglandin E2 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of alpha, Prostaglandin E2 to their clients by showing that a alpha, Prostaglandin E2 CEP has been issued for it. The manufacturer submits a alpha, Prostaglandin E2 CEP (COS) as part of the market authorization procedure, and it takes on the role of a alpha, Prostaglandin E2 CEP holder for the record. Additionally, the data presented in the alpha, Prostaglandin E2 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the alpha, Prostaglandin E2 DMF.
A alpha, Prostaglandin E2 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. alpha, Prostaglandin E2 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of alpha, Prostaglandin E2 suppliers with CEP (COS) on PharmaCompass.